Cordlife strengthens pan India presence
Cordlife, Asia's largest and the most experienced network of stem cell banks in the Asia Pacific region, has announced the commencement of 50 collection centres nationally.
With the new centre coming up in Punjab, Cordlife has set its footprint pan India.
The addition of the new collection centre has strengthened its position as a serious and leading player in the stemcell banking market, said the company.
The new launch by Cordlife has also established its foundation in the North where it has registered a growth of 9pc from the last quarter thus increasing the sales margin and reach.
The field of stemcell research is ever-growing as new diseases are coming under the purview of stemcell therapy.
Stem cell therapies are being developed for rare genetic disorders and for the treatment of terminal diseases like heart disease, orthopaedic complications, breast cancer and other life threatening ailments.
Cordlife said Punjab was already in the company's radar as a part of the expansion plan since it has already covered Delhi and UP.
Cordlife said it plans to cover all the important markets in Punjab like Chandigarh, Ludhiana, Amritsar, Bhatinda etc.
"We look forward to educating the doctors and would-be parents about stemcell banking and its implications for therapeutic usage in these regions," said Meghnath Roy Chowdhury, Managing Director - Cordlife India.
"The new collection centre adds on to the options available for would-be parents in planning for a healthy future for their child," Chowdhury said.